<?xml version="1.0" encoding="UTF-8"?>
<p id="para0028">
 <italic>TMPRSS2</italic> gene is an androgen responsive gene 
 <xref rid="bib0030" ref-type="bibr">[30]</xref>. Given the key role of this protease in SARS-CoV-2 entry into the host cells, anti-androgenic agents, such as bicalutamide and enzalutamide are being tested in prospective phase 2 clinical trials in patients with COVID-19.
</p>
